Summary. Techniques currently available to detect Shiga-like toxin (SLT)-producing Escherichia coli lack sensitivity or require specialised equipment and facilities, and in some cases detect only strains belonging to serotype 0157. We have used an ELISA technique, capable of detecting both SLTI and SLTII with crude P1 glycoprotein from hydatid cysts, in combination with enhancement of toxin production by culture with mitomycin C. Supernates of Tryptone Soya Broth cultures containing mitomycin C 200 ng/ml were tested for SLTII. For SLTI, cell lysates pre-treated with polymyxin B were tested. In tests with E. coli 0 1 57 : H7 in mixed culture with E. coli strain C600 alone, or with E. coli C600, Proteus mirabilis and Enterococcus faecalis, SLTI could be detected when the proportion of toxigenic organisms represented 1% of the mixture, and SLTII when the proportion was 0.025%. When faecal samples with added E. coli 0157 : H7 were examined in this system, SLTII-producing strains were detected when they comprised <0.1% of the coliform population. This technique is a sensitive and specific assay for detecting low numbers of SLT-producing organisms in mixed culture such as occurs in cases of haemolytic uraemic syndrome and haemorrhagic colitis.
Introduction
Enteric infections complicated by haemorrhagic colitis (HC) or the haemolytic uraemic syndrome (HUS) are commonly associated with Escherichia coli strains that produce cytotoxins. 1-4 These cytotoxins occur in two principal forms-Shiga-like toxin (SLT) I, which is almost identical to the toxin elaborated by Shigella dysenteriae type 1, and SLTII which, although immunologically distinct from SLTI, shares approximately 60% amino-acid h~mology.~ The subunit structure, mechanism of action and biological activity (enterotoxicity, neurotoxicity and cytotoxicity) are similar for SLTI and 11,' and both toxins bind to globotriaosyl ceramide (Gb3) which may be an important receptor in vivo. 6 In most strains of SLTproducing E. coli, the toxin genes are carried by bacteriophage . 4 The laboratory diagnosis of infection with SLTproducing E. colican be difficult. In many laboratories, diagnosis is made by faecal culture on sorbitolMacConkey agar to isolate strains of E. coli serotype 0157 which are sorbitol non-fermenters, followed by agglutination with specific antisera. ' However, this technique may produce false positive results because of isolation of non-toxigenic strains of E. coli 0157 and E. herrnar~ii.~ Of greater importance is the failure of this technique to detect sorbitol-fermenting SLTproducing strains of E. coli of serotypes other than 0 1 57, which are frequently implicated as causes of HC and HUS.lv8 A recent study in the UK showed that only 72% of infections with cytotoxin-producing E. coli were caused by strains belonging to serotype 0157;8 thus 28% of strains would ferment sorbitol and would not be detected by this method.
Other techniques to detect SLTs are available. In laboratories with tissue-culture facilities, direct inoculation of filtered faecal suspensions on to susceptible cell lines, or examination of E. coli culture supernates or cell lysates can be performed.' However, the specificity of any cytotoxic activity must be confirmed with appropriate neutralising antibodies. Detection of toxin genes with DNA probes,'-' ' with or without the polymerase chain reaction (PCR),' 2 9 is an alternative approach.
ELISA techniques have also been developed for detection of Shiga-like toxin with monoclonal antib~dies'~ or Gb3lS9 l 6 to bind toxin. Recently, P1 glycoprotein from hydatid cyst fluid, which contains the same terminal Galal-4 Gal disaccharide as Gb3, has been used to bind SLTI and I1 for both toxin p~rification'~ and quantitation by ELISA. '* A major problem in the diagnosis of SLT-producing E. coli in HUS and HC is that the numbers of toxinproducing organisms decreases as the disease progresses,* ' such that the number of toxin-producing E.
coli represents <1% of the total faecal E. coli population. ' l 2y * Therefore, tests aimed at detecting toxin-producing organisms must have adequate sensitivity and be as rapid as possible.
In this study we have used an ELISA, in combination with culture in the presence of mitomycin C, to develop an easily applicable and sensitive assay for the detection of SLTI-and 11-producing organisms.
Materials and methods

Bacterial strains
The following strains were used throughout the study. E. coli K-12 strain C600 was used as a non-SLT producing control. Strain C600 lysogenised with phage 9335 or 933W was used as a producer of either SLTI or SLTII, respectively, and E. coli 0157:H7 strain 933, which produces both SLTI and 11, was used as the toxin-producing strain. All were kindly provided by the late Dr H. Williams-Smith. A clinical isolate of E. coli 0 1 57 : H7 producing SLTII only was used in some experiments.
A strain of Proteus mirabilis and a strain of Enterococcus faecalis isolated from a faecal sample were used in combination with E. coli C600 to simulate mixed faecal flora.
Cultural conditions and preparation of mixed cultures
Bacteria grown in Tryptone Soya Broth (TSB; Difco) overnight at 37°C were used to inoculate TSB or TSB containing mitomycin C (Sigma). Cultures were then incubated at 37°C for 18 h with shaking (1 10 rpm). Initially, mitomycin C was added at a range of concentrations of 0-1000 ng/ml to determine the optimal concentration required for production of SLT by E. coli 0157: H7 strain 933.
Mixed cultures were prepared by inoculating 8 pl of dilutions (25-10 000) of a culture of E. coli 0157:H7 strain 933 and an equal volume of a culture of E. coli strain C600 or an equal mixture of E. coli C600, P . rnirabilis and Ent. faecalis into TSB. Viable counts (cfulml) were performed on CLED Agar (Lab M) on the culture used as the inoculum and on the mixture following overnight incubation.
Preparation of faecal samples
Faeces (c. 4g) from a patient with diarrhoea was suspended in 10 ml of PBS and the cfufg of faeces was determined on CLED agar. The remaining faecal sample was stored at 4°C. Following the determination of the viable count, a freshly prepared suspension of the faecal sample was used to inoculate a series of broths containing mitomycin C 200 ng/ml with c. lo6-lo7 cfu. Dilutions of the E. coli 0157:H7 strain 933 were then added. Viable counts were performed on the faecal sample and the E. coli 0157 : H7 culture to determine the proportions of faecal : toxigenic organisms in the mixture. A broth inoculated with the faecal suspension alone served as a control. This procedure was repeated with two other faecal samples.
Preparation of culture supernates and cell lysates
After overnight incubation, the cultures were centrifuged for 10 min at 3000 g. For SLTII, supernates were harvested and assayed by ELISA. For SLTI, cell pellets were resuspended in 300 pl of polymyxin B (Sigma) 2 mgfml in PBS, vortex mixed and incubated at 37°C for 15 min. The lysate was centrifuged in a bench top microfuge for 2 min and the clear supernate was assayed by ELISA. Polymyxin lysis of cell pellets gave at least a five-fold increase in the yield of SLTI.
ELISA
SLTI and 11 were assayed by an ELISA technique as previously described. Briefly, ELISA plates (Nunc Immunoplates) were coated with crude hydatid cyst material17 10 pg/ml in PBS, and then blocked with bovine serum albumin 1%. Supernate or cell lysate preparations were added and bound toxin was detected with rabbit polyclonal antibodies raised against the two toxins separately.16 A goat anti-rabbit IgG conjugated to alkaline phosphatase (Sigma) followed by substrate (nitrophenol phosphate ; Sigma) was used to detect bound polyclonal antibody. Absorbance was measured at 410 nm. To quantify the amount of toxin in the preparation, Shiga toxin and SLTII, purified as described previously,16 were diluted in PBS and used as standards in the ELISA.
Results
Experiments to determine the concentration of mitomycin C for the maximal induction of toxin in E. coli 0157:H7 strain 933 showed that 200 ngfml was optimal (table I). This concentration was used in subsequent experiments.
The ELISA was able to detect 1.6 ng of purified Shiga toxin (SLTI) and 1.6 ng of SLTII per ml. It was confirmed that E. coli strain C600 (9335) produced SLTI only and E. coli C600 (933W) produced SLTII only. E. coli0157 : H7 strain 933 produced both toxins. Comparison of cultures of these three strains grown with and without mitomycin C 200 ng/ml showed that toxin titres were markedly increased in all three strains by growth in the presence of mitomycin C (table 11). Similar results were obtained with a mixed culture of P . mirabilis, Ent. faecalis and E. coli strain C600 incubated with E. coli 0157: H7 strain 933 (tables I11 and IV). Detection of SLTI in cell lysates was possible when the proportion of toxin producers was 0.5%, and, for SLTII, positive reactions were found when the proportion of toxin producers was 0.0125-0.025% (tables 111 and IV). When the experiment was conducted in the absence of mitomycin C, SLTI was detected only in pure cultures and SLTII in cultures comprising 0.5% of toxin-producing organisms (tables I11 and IV).
When a different clinical isolate of E. coli 0 1 57 : H7 which produced SLTI, was co-inoculated with the three-organisms mixture, SLTII production was also detectable when the proportion of the toxin-producer was as low as 0.1 %.
With three different faecal samples seeded with E. coli 0157:H7 strain 933, SLTII was detected when the proportion of toxigenic organisms was < 0.1% in all three samples and <0-05% in one case. In each case, SLTII was not detected in any of the faecal samples inoculated into broth without the E. coli 0157:H7 strain. These samples were not examined for SLTI production.
Discussion
ND, not detected.
When E. coli 0 157 : H7 strain 933 was co-inoculated at different dilutions with a fixed number (lo7) of E. coli C600 into broth containing mitomycin C, it was possible to detect SLTI in cell lysates when the proportion of toxin-producing cells at inoculation was 0.5% (table 111) . However, detection of SLTII in supernates was possible when the proportion of strains was 0.0125-0-025% (table IV) .
Diagnosis of E. coli infections which are associated with HC or HUS requires a rapid, specific and sensitive laboratory test. Existing techniques, such as sorbitol MacConkey agar, lack specificity, others such as tissue culture cytotoxin tests lack speed or are not readily available, e.g., DNA probes and PCR. ELISAs to detect toxins have been developed with various techniques, and are able to detect very small (ng) quantities of either SLTI or SLTII. Thus, although less sensitive than tissue culture, ELISAs do offer Table 111 . Detection of SLTI, determined by ELISA with cell lysates of E. coli 0 1 57 : H7 strain 933 grown in TSB (with or without mitomycin C 200 ng/ml) in variable proportions with either E. coli strain C600 or a mixture of E. coli C600, P . mirabilis and Ent. faecalis The sensitivity of the current ELISA was 1-6 ng/ml for SLTI and 11, which is comparable to the sensitivity of a previously described ELISA with Gb3 as the capture system." To increase the sensitivity of our assay, toxin yields of the organisms were increased by growth in broth containing mitomycin C . This enhanced the yield of both SLTI and SLTII from E. coli 0157 : H7 strain 933 > 100-fold compared with growth in cultures without mitomycin C .
The mechanism whereby mitomycin C increases toxin yields is not fully understood but may be a consequence of bacteriophage induction (D. W. K. Acheson, unpublished observations). The increase in phage particles and hence viral gene copies brought about by mitomycin C suggests that this compound amplifies the number of toxin genes per bacterial cell and may increase the sensitivity of DNA probes for these toxins. The enhancement of toxin production by mitomycin C also has potential for other methods of detection of SLT-producting E. coli.
Currently we have no explanation for the marked differences in the level of SLTI and SLTII produced by E. coli 0157:H7 strain 933. The lower levels of SLTI prevented detection of small numbers of this organism, methods to improve the yields of SLTI are being evaluated.
When E. coli strain C600 alone or mixtures of E. coli C600, P . rnirabilis and En?. faecalis were co-inoculated with varying numbers of E. coli 0157: H7 strain 933 and grown in broth containing mitomycin C , SLTI was detected when the proportion of the E. coli 0157:H7 strain was 0.5-1% of the population. Detection of SLTII however was achieved when E. coli 0 1 57 : H7 represented only 0.0 125-O.025% of the total. In tests with faecal samples seeded with E. coli 0157:H7 strain 933, SLTII was detected when the organism comprised < 0.1% of the aerobic flora. This may be important because several studies have shown that, in cases of HUS, the number of cytotoxinproducing organisms was < 1 %. 7 *-l o The system described in this study provides a simple means of diagnosing infection with SLT-producing E. coli even when the organisms are present in low numbers. The technique must now be evaluated with clinical samples from patients with HC or HUS. The technique is easily applicable in routine diagnostic laboratories without the need for expensive equipment or expertise. However, at the present time antibodies to SLT are not widely available. Commercial development of an SLT assay would be welcomed.
There is growing evidence that SLTII-producing E. coli are more important than SLTI-producing E. coli in the pathogenesis of HC and HUS.239'4 This may reflect the much higher yields of SLTII compared with SLTI, a greater intrinsic toxicity of SLTII compared with SLTI,23 or a greater prevalence of SLTIIproducing strains. A recent survey in the UK showed that 83% of E. coli strains from HC or HUS cases produced SLTII only, whereas 5.6% of strains produced SLTI only and 11.3% of strains produced both toxins.* Therefore, an assay that is able to detect low numbers of SLTII-producing strains would be highly advantageous for diagnostic purposes. 
